ProUroCare Medical Inc. announced that life sciences veteran Doris Engibous has entered into a contract to act as its interim Chief Operating Officer. Ms. Engibous' primary assignment during this interim period is to direct activities leading to a 510(k) submission for a reusable probe for the ProUroScan system, the placements of systems at key opinion leader sites, and the production of systems in advance of market launch.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2014 | ProUroCare Medical Inc. Announces Resignation of Robert Rudelius from the Board of Directors | CI |
2013 | ProUroCare Medical Inc. announced that it expects to receive $0.50 million in funding. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.86K | |
-2.78% | 15.11B | |
-12.11% | 2.48B | |
-14.23% | 1.43B | |
-.--% | 1.12B | |
+60.75% | 614M | |
+88.21% | 509M | |
+22.63% | 260M | |
-2.35% | 227M | |
+7.96% | 198M |
- Stock Market
- Equities
- PUMD Stock
- News ProUroCare Medical Inc.
- ProUroCare Medical Inc. Appoints Doris Engibous as Interim Chief Operating Officer